National Health Investors (NYSE:NHI – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.590-4.660 for the period, compared to the consensus estimate of 4.690. The company issued revenue guidance of -.
Wall Street Analyst Weigh In
Separately, Truist Financial reduced their price objective on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating on the stock in a research report on Monday, December 23rd. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, National Health Investors presently has an average rating of “Moderate Buy” and an average price target of $76.60.
View Our Latest Research Report on National Health Investors
National Health Investors Stock Up 0.9 %
National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.03. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. As a group, equities research analysts forecast that National Health Investors will post 4.41 earnings per share for the current fiscal year.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- What Are Dividend Achievers? An Introduction
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- 3 Healthcare Dividend Stocks to Buy
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Overbought Stocks Explained: Should You Trade Them?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.